Monetta Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,700
Closed -$1.04M 48
2024
Q1
$1.04M Hold
5,700
0.94% 27
2023
Q4
$883K Buy
+5,700
New +$831K 0.84% 35
2022
Q3
Sell
-4,000
Closed -$613K 56
2022
Q2
$613K Sell
4,000
-2,000
-33% -$306K 0.64% 34
2022
Q1
$973K Hold
6,000
0.81% 25
2021
Q4
$812K Buy
+6,000
New +$709K 0.63% 32
2016
Q4
Sell
-27,500
Closed -$1.73M 60
2016
Q3
$1.73M Hold
27,500
1.11% 33
2016
Q2
$1.7M Buy
+27,500
New +$1.68M 1.08% 33

Other funds holding ABBV

Monetta Financial Services's ABBV Position: Q2 2024 in Review

Monetta Financial Services sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 5,700 shares — an estimated $1.04M sold.

Monetta Financial Services first reported a position in ABBV in Q2 2016 and held it in 7 quarters. The position peaked at $1.73M in Q3 2016. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Monetta Financial Services reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Monetta Financial Services sold 5,700 AbbVie shares in Q2 2024, an estimated $1.04M.
  • Monetta Financial Services first reported a position in AbbVie in Q2 2016 and held it in 7 quarters.
  • Monetta Financial Services's AbbVie position peaked at $1.73M in Q3 2016.
  • 3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Monetta Financial Services's 13F filing for Q2 2024, filed 9 Aug 2024.